 | Michael J. G. Farthing, Peter Malfertheiner - 2002 - 140 páginas
...gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-6. 25. Demetri GD, von Mehren M, Blanke CD. el al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engt J Med 2002; 347: 472-80. Basic Mechanisms iif Di/trxlive Diseases: the Kaliimalr fur Clinical... | |
 | Antonio Llombart Bosch, Vicente Felipo - 2003 - 312 páginas
...1 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344:1052-6. 4. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy...advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347:472-80. 150 GEORGE, D. 5. van Oosterom AT, Judson I, Verweij J, et al. Safety and efficacy... | |
 | Frédérique Penault-Llorca - 2003 - 102 páginas
...Piccart M. HER2/neu as a predictive factor in breast cancer. Clin Breust Cancer 2001 ; 2 (2) : 129-35. 3. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy...in Advanced Gastrointestinal Stromal Tumors. N Engl / Meii 2002 ; 347 : 472-80. 4. Baselga J, Tripathy D, Mendelhson J, et al. Phase II study of weekly... | |
 | Stan B. Kaye`, Stan B Kaye - 2004 - 558 páginas
...in a patient with a metastatic gastrointestinal stromal tumor. N Engl I Med 2001; 344: 1052-6. 43. Demetri GD, von Mehren M, Blanke CD et al. Efficacy...in advanced gastrointestinal stromal tumors. N Engl I Med 2002; 347; 472-80. 44. van Oosterom AT, Iudson IR, Verweij I et al. Update of phase I study of... | |
 | Ralph Rapley, Stuart Harbron - 2005 - 391 páginas
...Struct Biol 12: 14-20. Demetri, GD, von Mehren, M., Blanke, CD, Van den Abbeele, AD, et al. (2002) Efficacy and safety of imatinib mesylate in advanced...gastrointestinal stromal tumors. N Engl J Med 347: 472-480. Dhillon, AS and Kolch, W. (2002) Untying the regulation of the Raf-1 kinase. Arch Biochem Biophys 404:... | |
 | Steven L. Gersen, Martha B. Keagle - 2008 - 589 páginas
...gastrointestinal stromal tumors. Science 299, 708-710. 101. Demetri, GD, von Mehren, M., Blanke, CD, et al. (2002) Efficacy and safety of imatinib mesylate in advanced...gastrointestinal stromal tumors. N. Engl. J. Med. 347, 472-480. 102. van Oosterom, AT, Judson, I., Verweij, J., et al. (2001) Safety and efficacy of imatinib (STI571)... | |
 | Charles Brenner, David Duggan - 2004 - 400 páginas
...Demetri. G.. Von Mehren. M.. Blanke. CD. Van Den Abbeele. AD. Eisenberg. B.. Roberts. PJ. et al. t2002). Efficacy and safety of imatinib mesylate in advanced...gastrointestinal stromal tumors. N Engl J Med 347 t7). 472-480. Eckhardt. SG. Baker. SD. Brinen. CD, Hidalgo. M.. Siu. L.. Hammond. LA. et al. t2000).... | |
 | Edward Chu - 2004 - 178 páginas
...Docetaxel for gastric and esophageal carcinomas. Oncology 2002;16 (Suppl 6):89-96. 136. Demetri GD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N EnglJ Ued 2002;347:472-480. 137. Shin DS, et al. Phase II trial of paclitaxel, ifosfamide, and cisplatin... | |
 | Merrill Goozner - 2004 - 304 páginas
...Novartis on the Spot," Wall Street Journal, June 6, 2000. 76. Moore, "Blood Test." See also GD Demetri et al., "Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors," New England Journal of Medicine, Aug. 15, 2002, pp. 472-80. The financial disclosure statements in... | |
 | Doriano Fabbro, Frank McCormick - 2007 - 599 páginas
...rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med 2002; 347:481^87. 137. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy...advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347:472^180. 138. Zhao M, Kiyoi H, Yamamoto Y, et al. In vivo treatment of mutant FLT3-transformed... | |
| |
Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. 
